Walleye Trading
ADPT icon

Walleye Trading’s Adaptive Biotechnologies ADPT Stock Holding History

Walleye Trading’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,555
Closed -$71.6K – 5246
2021
Q4 		$128K Buy
+4,555
New +$140K ﹤0.01% 4239
2021
Q2 		– Sell
-3,232
Closed -$130K – 5087
2021
Q1 		$130K Buy
+3,232
New +$175K ﹤0.01% 3951

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's ADPT Position: Q1 2022 in Review

Walleye Trading sold out of Adaptive Biotechnologies (ADPT) in Q1 2022, closing a stake of 4,555 shares — an estimated $71.6K sold.

Walleye Trading first reported a position in ADPT in Q1 2021 and held it in 2 quarters. The position peaked at $130K in Q1 2021. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

  • Walleye Trading reported no remaining Adaptive Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 4,555 Adaptive Biotechnologies shares in Q1 2022, an estimated $71.6K.
  • Walleye Trading first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 2 quarters.
  • Walleye Trading's Adaptive Biotechnologies position peaked at $130K in Q1 2021.
  • 221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.